A novel role for STAT3 in cardiac remodeling

被引:61
作者
Yamauchi-Takihara, K [1 ]
Kishimoto, T [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Mol Med, Suita, Osaka 5650871, Japan
关键词
D O I
10.1016/S1050-1738(01)00066-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The binding of ligands to gp130 activates the JAK/STAT signal transduction pathway, where STAT3 plays a central role in transmitting signals from the membrane to the nucleus. STAT3 is essential for gp130-mediated cardiac myocte hypertrophy. Cardiac-specific disruption of gp130 was shown to present heart failure in response to mechanical stress accompanied by an increase in apoptosis. Thus, the inactivation of STAT3 resulting from the loss of gp130 may be a key event in the transition from cardiac hypertrophy to heart failure. Proper vascular growth is essential for normal cardiac development and remodeling process. Recently bcl-xL and VEGF have identified as target genes of STAT and together can promote cardiac myocyte survival by prevention of apoptosis and restoration of energy deprivation. In this review, STAT3 is highlighted as a regulator of angiogenic factors, and activation of STAT-mediated signaling in the cardiac myocyte is proposed as a novel therapeutic strategy for the prevention of heart failure. (Trends Cardiovasc Med 2000; 10:298-303). (C) 2001, Elsevier Science Inc,
引用
收藏
页码:298 / 303
页数:6
相关论文
共 58 条
[1]   Stat3 as an oncogene [J].
Bromberg, JF ;
Wrzeszczynska, MH ;
Devgan, G ;
Zhao, YX ;
Pestell, RG ;
Albanese, C ;
Darnell, JE .
CELL, 1999, 98 (03) :295-303
[2]   PROTEIN-KINASE-B (C-AKT) IN PHOSPHATIDYLINOSITOL-3-OH INASE SIGNAL-TRANSDUCTION [J].
BURGERING, BMT ;
COFFER, PJ .
NATURE, 1995, 376 (6541) :599-602
[3]  
BUZDAR AU, 1985, CANCER, V55, P2761, DOI 10.1002/1097-0142(19850615)55:12<2761::AID-CNCR2820551206>3.0.CO
[4]  
2-P
[5]   Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188 [J].
Carmeliet, P ;
Ng, YS ;
Nuyens, D ;
Theilmeier, G ;
Brusselmans, K ;
Cornelissen, I ;
Ehler, E ;
Kakkar, VV ;
Stalmans, I ;
Mattot, V ;
Perriard, JC ;
Dewerchin, M ;
Flameng, W ;
Nagy, A ;
Lupu, F ;
Moons, L ;
Collen, D ;
D'Amore, PA ;
Shima, DT .
NATURE MEDICINE, 1999, 5 (05) :495-502
[6]   Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele [J].
Carmeliet, P ;
Ferreira, V ;
Breier, G ;
Pollefeyt, S ;
Kieckens, L ;
Gertsenstein, M ;
Fahrig, M ;
Vandenhoeck, A ;
Harpal, K ;
Eberhardt, C ;
Declercq, C ;
Pawling, J ;
Moons, L ;
Collen, D ;
Risau, W ;
Nagy, A .
NATURE, 1996, 380 (6573) :435-439
[7]   Stress pathways and heart failure [J].
Chien, KR .
CELL, 1999, 98 (05) :555-558
[8]   Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: A novel mechanism for cardiomyopathy and muscular dystrophy [J].
Coral-Vazquez, R ;
Cohn, RD ;
Moore, SA ;
Hill, JA ;
Weiss, RM ;
Davisson, RL ;
Straub, V ;
Barresi, R ;
Bansal, D ;
Hrstka, RF ;
Williamson, R ;
Campbell, KP .
CELL, 1999, 98 (04) :465-474
[9]   Regulation of neuronal survival by the serine-threonine protein kinase Akt [J].
Dudek, H ;
Datta, SR ;
Franke, TF ;
Birnbaum, MJ ;
Yao, RJ ;
Cooper, GM ;
Segal, RA ;
Kaplan, DR ;
Greenberg, ME .
SCIENCE, 1997, 275 (5300) :661-665
[10]   INSULIN-LIKE GROWTH-FACTOR-I ENHANCES VENTRICULAR HYPERTROPHY AND FUNCTION DURING THE ONSET OF EXPERIMENTAL CARDIAC-FAILURE [J].
DUERR, RL ;
HUANG, S ;
MIRALIAKBAR, HR ;
CLARK, R ;
CHIEN, KR ;
ROSS, J .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (02) :619-627